通过专为投资者打造的一站式数据看板，全面查看 CRISPR Therapeutics AG 的财务状况。平台将复杂的财务报表整理为可自定义的视图，助您更轻松地进行财务分析。您可以查看最新年度财务报告，也可以通过利润表、资产负债表和现金流量表，按季度分析公司表现。借助实时财务指标，持续追踪公司的经营状况和市场表现更加便捷。

关键财务比率

总市值

5.65B

股息TTM

0.00

市盈率 TTM

-9.48

每股收益TTM

-6.16

营业收入

3.51M

净利润

-366.25M

净资产收益率

-31.21%

总资产收益率

-23.24%

CRISPR Therapeutics AG 财报日历

财务报表摘要

单季报

单季报+年报

单季报

年报

YOY

隐藏空白行

FY2026Q2

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

财务指标

每股收益

60.57%-0.94

19.12%-1.28

-213.87%-1.37

-15.62%-1.17

-60.91%-2.40

-11.02%-1.58

-138.94%-0.44

28.60%-1.01

-51.44%-1.49

-111.34%-1.43

179.51%1.12

---1.41

---0.98

---0.67

---1.41

---6.96

----

营业收入

1041.37%10.18M

68.55%1.46M

-97.58%864.00K

47.67%889.00K

72.53%892.00K

71.63%865.00K

-82.26%35.69M

--602.00K

-99.26%517.00K

-99.50%504.00K

3353333.33%201.21M

-100.00%0.00

44203.80%70.00M

10538.30%100.00M

-99.95%6.00K

-88.59%94.00K

-99.98%158.00K

74.40%940.00K

3386.22%12.90M

456.76%824.00K

净利润

56.29%-91.15M

9.61%-122.93M

-250.07%-130.61M

-23.85%-106.44M

-64.98%-208.55M

-16.64%-136.00M

-141.76%-37.31M

23.37%-85.94M

-62.60%-126.41M

-119.71%-116.59M

180.80%89.35M

35.75%-112.15M

58.17%-77.74M

70.39%-53.06M

21.72%-110.58M

-37.27%-174.55M

-124.48%-185.83M

-58.37%-179.22M

-31.96%-141.25M

-37.55%-127.15M

利润率

96.17%-895.33%

46.37%-8431.48%

-14360.87%-15117.25%

16.13%-11973.12%

4.38%-23379.93%

32.04%-15722.08%

-335.42%-104.54%

---14276.08%

-21915.96%-24450.29%

-43493.96%-23133.13%

100.00%44.41%

----

---111.06%

---53.06%

---1842916.67%

---45268.46%

----

毛利率

0.00%100.00%

--100.00%

0.00%100.00%

----

--100.00%

----

资产负债率

--22.11%

--21.48%

----

利润表

营业收入

1041.37%10.18M

68.55%1.46M

-97.58%864.00K

47.67%889.00K

72.53%892.00K

71.63%865.00K

-82.26%35.69M

--602.00K

-99.26%517.00K

-99.50%504.00K

3353333.33%201.21M

-100.00%0.00

44203.80%70.00M

10538.30%100.00M

-99.95%6.00K

-88.59%94.00K

-99.98%158.00K

74.40%940.00K

3386.22%12.90M

456.76%824.00K

营业利润

13.73%-114.80M

12.25%-130.25M

-139.62%-154.76M

-19.91%-132.06M

12.02%-133.07M

-5.57%-148.42M

-192.82%-64.59M

16.83%-110.13M

-58.85%-151.26M

-118.01%-140.59M

152.90%69.58M

27.40%-132.41M

48.04%-95.22M

63.35%-64.49M

9.72%-131.54M

-41.55%-182.39M

-124.03%-183.26M

-53.63%-175.97M

-35.20%-145.70M

-39.45%-128.85M

净利润

56.29%-91.15M

9.61%-122.93M

-250.07%-130.61M

-23.85%-106.44M

-64.98%-208.55M

-16.64%-136.00M

-141.76%-37.31M

23.37%-85.94M

-62.60%-126.41M

-119.71%-116.59M

180.80%89.35M

35.75%-112.15M

58.17%-77.74M

70.39%-53.06M

21.72%-110.58M

-37.27%-174.55M

-124.48%-185.83M

-58.37%-179.22M

-31.96%-141.25M

-37.55%-127.15M

资产负债表

流动资产

36.81%2.37B

31.10%2.45B

2.51%1.99B

-0.76%1.93B

-13.77%1.73B

-11.89%1.87B

1.52%1.94B

10.41%1.94B

8.11%2.01B

11.09%2.12B

2.97%1.91B

-8.91%1.76B

-11.75%1.86B

-15.60%1.91B

-23.35%1.85B

-23.27%1.93B

-19.61%2.11B

23.37%2.26B

40.83%2.42B

81.10%2.52B

流动负债总额

27.34%132.90M

14.10%136.29M

69.88%149.12M

32.45%118.96M

-18.35%104.36M

0.38%119.45M

-19.31%87.78M

-19.26%89.81M

-3.77%127.82M

-18.94%118.99M

-10.17%108.79M

-26.27%111.23M

10.74%132.84M

29.11%146.79M

1.02%121.11M

56.82%150.87M

20.05%119.96M

36.84%113.70M

27.18%119.88M

14.33%96.21M

总资产

30.60%2.65B

25.84%2.73B

1.04%2.27B

-0.48%2.25B

-13.25%2.03B

-11.19%2.17B

0.56%2.24B

8.11%2.26B

6.50%2.34B

8.67%2.44B

-0.60%2.23B

-11.33%2.09B

-10.81%2.20B

-13.88%2.24B

-18.49%2.24B

-16.60%2.35B

-15.04%2.46B

33.11%2.61B

50.54%2.75B

90.01%2.82B

总负债

183.82%904.22M

170.45%911.26M

10.80%343.43M

4.06%329.33M

-11.23%318.59M

-5.11%336.94M

-10.62%309.95M

-11.86%316.47M

-5.80%358.90M

-8.83%355.08M

-5.66%346.77M

-10.11%359.04M

2.27%380.99M

7.81%389.47M

4.30%367.58M

29.34%399.40M

25.97%372.53M

137.03%361.26M

115.24%352.42M

117.90%308.80M

总权益

2.07%1.75B

-0.80%1.81B

-0.53%1.92B

-1.22%1.92B

-13.62%1.71B

-12.23%1.83B

2.62%1.93B

12.26%1.94B

9.08%1.98B

12.35%2.08B

0.39%1.88B

-11.57%1.73B

-13.14%1.82B

-17.37%1.85B

-21.84%1.88B

-22.24%1.95B

-19.70%2.09B

24.34%2.24B

44.18%2.40B

87.07%2.51B

现金流量表

经营净额

26.68%-83.50M

-101.86%-108.90M

-84.99%-92.55M

20.84%-84.63M

-19.14%-113.88M

-149.15%-53.95M

47.92%-50.03M

-168.25%-106.91M

28.27%-95.58M

1147.32%109.75M

15.23%-96.07M

62.12%-39.86M

6.14%-133.25M

106.51%8.80M

-31.72%-113.33M

-29.37%-105.22M

-117.59%-141.96M

-34.35%-135.24M

-5.94%-86.04M

-7.44%-81.33M

投资净额

-179.54%-55.66M

-1979.19%-410.74M

-64.85%37.20M

26.22%-119.23M

155.14%69.98M

79.80%-19.75M

229.93%105.83M

-233.17%-161.60M

-158.50%-126.91M

-183.00%-97.80M

53.60%-81.45M

38.74%121.35M

486.87%216.92M

202.89%117.83M

-1913.91%-175.53M

115.48%87.46M

80.90%-56.07M

31.79%-114.52M

95.73%-8.72M

-71.10%-565.18M

融资净额

217.98%7.18M

5490.37%591.91M

589.82%116.41M

2978.49%296.77M

584.55%2.26M

-96.54%10.59M

-56.66%16.88M

519.54%9.64M

-102.78%-466.00K

5561.25%305.93M

1471.39%38.94M

-89.70%1.56M

61.93%16.77M

-49.25%5.40M

-60.66%2.48M

47.98%15.11M

22.62%10.35M

-95.29%10.65M

-98.47%6.30M

-98.01%10.21M

常见问题

CRISPR Therapeutics AG的总收入是多少？



根据CRISPR Therapeutics AG的FY2025财报，总收入达到了3.51M（同比变化37.31M）。

CRISPR Therapeutics AG的流动资产是多少？



根据CRISPR Therapeutics AG的FY2025财报，流动资产为1.99B（同比变化2.51）。

CRISPR Therapeutics AG的总资产是多少？



根据CRISPR Therapeutics AG的FY2025财报，CRISPR Therapeutics AG的总资产为2.27B（同比变化1.04）。

CRISPR Therapeutics AG的总负债是多少？



根据CRISPR Therapeutics AG的FY2025财报，CRISPR Therapeutics AG的总负债为343.43M（同比变化10.80）。

CRISPR Therapeutics AG的总权益是多少？



根据CRISPR Therapeutics AG的FY2025财报，CRISPR Therapeutics AG的总权益为1.92B（同比变化-0.53）。

CRISPR Therapeutics AG的净营业收入是多少？



根据CRISPR Therapeutics AG的FY2025财报，CRISPR Therapeutics AG的净营业收入为-568.32M（同比变化-21.81）。

CRISPR Therapeutics AG的净投资是多少？



根据CRISPR Therapeutics AG的FY2025财报，CRISPR Therapeutics AG的净投资为-31.80M（同比变化88.66）。

CRISPR Therapeutics AG的净融资是多少？



根据CRISPR Therapeutics AG的FY2025财报，CRISPR Therapeutics AG的净融资为426.03M（同比变化28.33）。

CRISPR Therapeutics AG的每股收益（EPS）是多少？



根据CRISPR Therapeutics AG的FY2025财报，每股收益（EPS）为-6.47（同比变化-48.97）。

CRISPR Therapeutics AG的净利润是多少？



根据CRISPR Therapeutics AG的FY2025财报，净利润为-581.60M（同比变化-58.80）。

CRISPR Therapeutics AG的净利润率是多少？



根据CRISPR Therapeutics AG的FY2025财报，净利润率为-16569.77（同比变化-1588.14）。

CRISPR Therapeutics AG的股东权益回报率（ROE）是多少？



根据CRISPR Therapeutics AG的FY2025财报，股东权益回报率（ROE）为-30.18（同比变化-57.19）。

CRISPR Therapeutics AG的资产回报率（ROA）是多少？



根据CRISPR Therapeutics AG的FY2025财报，资产回报率（ROA）为-25.81（同比变化-57.54）。

CRISPR Therapeutics AG的营业利润是多少？



根据CRISPR Therapeutics AG的FY2025财报，营业利润为-568.32M（同比变化-21.81）。